Browsing publications by Dr Luke Gaughan

Newcastle AuthorsTitleYearFull text
Dr Luke Gaughan
Dr Steven Darby
Professor Craig Robson
AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival2015
Dominic Jones
Dr Mark Wade
Jim Grey
Sirintra Nakjang
Wenrui Guo
et al.
Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy2015
Dominic Jones
Dr Mark Wade
Sirintra Nakjang
Lewis Chaytor
Jim Grey
et al.
FOXA1 regulates androgen receptor variant activity in models and castrate-resistant prostate cancer2015
Dr Helen Marr
Dr Luke Gaughan
Dr Susan Tudhope
Professor James Allan
Regulation of CD38 in IRF4 in Chronic Lymphocytic Leukaemia2015
Ahmed Abroaf
Dr Luke Gaughan
Professor Craig Robson
Dr Rakesh Heer
The co-chaperone p23 promotes prostate cancer motility and metastasis2015
Dr Mark Wade
Dominic Jones
Laura Wilson
Dr Jacqueline Stockley
Dr Kelly Coffey
et al.
The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer2015
Dr Urszula McClurg
Victoria Harle
Dr Scott Walker
Dr Kelly Coffey
Dr Luke Gaughan
et al.
Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer2015
Dr Urszula McClurg
Victoria Harle
Dr Luke Gaughan
Professor Craig Robson
Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathway2014
Daniel O'Neill
Dr Stuart Williamson
Dhuha Alkharaif
Dr Luke Gaughan
Professor Craig Robson
et al.
SETD6 controls the expression of estrogen-responsive genes and proliferation of breast carcinoma cells2014
Dr Steven Darby
Dr Luke Gaughan
Survival Outcome and EMT Suppression Mediated by a Lectin Domain Interaction of Endo180 and CD1472014
1234